Welp I'm back on topiramate for migraines and it's giving me some parasthesia (abnormal sensations). Closest I can come to explaining is to say that it feels like my head is in a big fizzy bag and it makes me feel stupid.

The headaches have almost stopped, so now I need to find another excuse to be tetchy and avoid people

#migraine #topiramate

My new medication is making me feel out of it, but I also feel calmer, so... decent trade-off, I guess. And I'm enjoying the decreased appetite. #Topiramate #BingeEatingDisorder
That numb feet #topiramate feeling #epilepsyawarenessday

Our #safety committee, the #PRAC, has started 2 reviews:
➑️ one for #topiramate use in pregnancy and the risk of neurodevelopmental disorders in children
➑️ one for #pholcodine-containing medicines due to concerns about the risk of developing severe allergy to other medicines

πŸ¦πŸ”—: https://nitter.eu/EMA_News/status/1565689936702996481

EU Medicines Agency (@EMA_News)

Our #safety committee, the #PRAC, has started 2 reviews: ➑️ one for #topiramate use in pregnancy and the risk of neurodevelopmental disorders in children ➑️ one for #pholcodine-containing medicines due to concerns about the risk of developing severe allergy to other medicines

Nitter

Our #safety committee, the #PRAC, recommended new measures to minimise the risk of #meningioma with πŸ’Š containing #nomegestrol or #chlormadinone.
It also started a review of risks of neurodevelopmental disorders with #topiramate.
πŸ‘‰https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-4-7-july-2022

πŸ¦πŸ”—: https://nitter.eu/EMA_News/status/1545355046187110406

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 July 2022 - European Medicines Agency

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 July 2022

European Medicines Agency